3.0.0
7248
2025-05-27T14:12:59Z
2025-05-27T14:12:59Z
House
H
HR
2024-02-06
118
[Congressional Record Volume 170, Number 21 (Tuesday, February 6, 2024)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. CARTER of Georgia:H.R. 7248.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8 of the ConstitutionThe single subject of this legislation is:To amend the Federal Food, Drug, and Cosmetic Act toestablish a process for the qualification of nonclinicaltesting methods to reduce and replace the use of animals innonclinical research, improve the predictivity of nonclinicaltesting methods, and reduce development time for a biologicalproduct or other drug, and for other purposes.[Page H503]
- hsif00
Energy and Commerce Committee
House
Standing
  - hsif14
Health Subcommittee
    - Referred to
2024-02-09T21:49:27Z
  - Referred To
2024-02-06T17:00:45Z

- FDA Modernization Act 3.0
118
5046
S
2024-12-16
Held at the desk.
14:40:35
  - Related bill
CRS
- 2024-02-09
  - hsif14
Health Subcommittee
1
House committee actions
Referred to the Subcommittee on Health.
Committee
- 2024-02-06
Referred to the House Committee on Energy and Commerce.
IntroReferral
H11100
2
House floor actions
  - hsif00
Energy and Commerce Committee
- 2024-02-06
Introduced in House
IntroReferral
Intro-H
9
Library of Congress
- 2024-02-06
Introduced in House
IntroReferral
1000
9
Library of Congress
- C001103
Rep. Carter, Earl L. "Buddy" [R-GA-1]
Earl
Carter
R
GA
L. "Buddy"
1
N
- B001300
Rep. Barragan, Nanette Diaz [D-CA-44]
Nanette
Barragan
D
CA
Diaz
44
2024-02-06
True
- H001086
Rep. Harshbarger, Diana [R-TN-1]
Diana
Harshbarger
R
TN
1
2024-02-06
True
- B001260
Rep. Buchanan, Vern [R-FL-16]
Vern
Buchanan
R
FL
16
2024-02-06
True
- C001125
Rep. Carter, Troy [D-LA-2]
Troy
Carter
D
LA
2
2024-02-06
True
- W000823
Rep. Waltz, Michael [R-FL-6]
Michael
Waltz
R
FL
6
2024-02-06
True
- D000216
Rep. DeLauro, Rosa L. [D-CT-3]
ROSA
DELAURO
D
CT
3
2024-02-06
True
- N000026
Rep. Nehls, Troy E. [R-TX-22]
Troy
Nehls
R
TX
E.
22
2024-02-06
True
- G000589
Rep. Gooden, Lance [R-TX-5]
Lance
Gooden
R
TX
5
2024-02-06
True
- C001120
Rep. Crenshaw, Dan [R-TX-2]
Dan
Crenshaw
R
TX
2
2024-02-06
True
- F000466
Rep. Fitzpatrick, Brian K. [R-PA-1]
Brian
Fitzpatrick
R
PA
K.
1
2024-02-06
True
- V000129
Rep. Valadao, David G. [R-CA-22]
David
Valadao
R
CA
G.
22
2024-02-13
False
- N000191
Rep. Neguse, Joe [D-CO-2]
Joe
Neguse
D
CO
2
2024-02-14
False
- B001257
Rep. Bilirakis, Gus M. [R-FL-12]
Gus
Bilirakis
R
FL
M.
12
2024-02-23
False
- D000230
Rep. Davis, Donald G. [D-NC-1]
Donald
Davis
D
NC
G.
1
2024-02-23
False
- G000583
Rep. Gottheimer, Josh [D-NJ-5]
Josh
Gottheimer
D
NJ
5
2024-02-29
False
- N000147
Del. Norton, Eleanor Holmes [D-DC-At Large]
Eleanor
Norton
D
DC
Holmes
0
2024-03-05
False
- G000599
Rep. Goldman, Daniel S. [D-NY-10]
Daniel
Goldman
D
NY
S.
10
2024-03-05
False
- R000305
Rep. Ross, Deborah K. [D-NC-2]
Deborah
Ross
D
NC
K.
2
2024-03-11
False
- P000620
Rep. Pettersen, Brittany [D-CO-7]
Brittany
Pettersen
D
CO
7
2024-03-19
False
- L000397
Rep. Lofgren, Zoe [D-CA-18]
Zoe
Lofgren
D
CA
18
2024-03-21
False
- T000468
Rep. Titus, Dina [D-NV-1]
Dina
Titus
D
NV
1
2024-03-22
False
- L000599
Rep. Lawler, Michael [R-NY-17]
Michael
Lawler
R
NY
17
2024-03-29
False
- O000019
Rep. Obernolte, Jay [R-CA-23]
Jay
Obernolte
R
CA
23
2024-04-05
False
- T000481
Rep. Tlaib, Rashida [D-MI-12]
Rashida
Tlaib
D
MI
12
2024-04-17
False
- B001309
Rep. Burchett, Tim [R-TN-2]
Tim
Burchett
R
TN
2
2024-04-19
False
- S000522
Rep. Smith, Christopher H. [R-NJ-4]
Christopher
Smith
R
NJ
H.
4
2024-04-19
False
- M000194
Rep. Mace, Nancy [R-SC-1]
Nancy
Mace
R
SC
1
2024-04-23
False
- F000471
Rep. Fitzgerald, Scott [R-WI-5]
Scott
Fitzgerald
R
WI
5
2024-05-01
False
- B001298
Rep. Bacon, Don [R-NE-2]
Don
Bacon
R
NE
2
2024-05-10
False
- M001225
Rep. Mullin, Kevin [D-CA-15]
Kevin
Mullin
D
CA
15
2024-05-14
False
- C001097
Rep. Cárdenas, Tony [D-CA-29]
Tony
Cárdenas
D
CA
29
2024-05-21
False
- C001126
Rep. Carey, Mike [R-OH-15]
Mike
Carey
R
OH
15
2024-06-03
False
- G000586
Rep. García, Jesús G. "Chuy" [D-IL-4]
Jesús
García
D
IL
G. "Chuy"
4
2024-06-05
False
- F000462
Rep. Frankel, Lois [D-FL-22]
Lois
Frankel
D
FL
22
2024-07-22
False
- C001080
Rep. Chu, Judy [D-CA-28]
Judy
Chu
D
CA
28
2024-07-22
False
- S001221
Rep. Scholten, Hillary J. [D-MI-3]
Hillary
Scholten
D
MI
J.
3
2024-08-16
False
- C001121
Rep. Crow, Jason [D-CO-6]
Jason
Crow
D
CO
6
2024-08-23
False
- D000632
Rep. D'Esposito, Anthony [R-NY-4]
Anthony
D'Esposito
R
NY
4
2024-08-23
False
- G000597
Rep. Garbarino, Andrew R. [R-NY-2]
Andrew
Garbarino
R
NY
R.
2
2024-09-03
False
- H001090
Rep. Harder, Josh [D-CA-9]
Josh
Harder
D
CA
9
2024-09-10
False
- N000002
Rep. Nadler, Jerrold [D-NY-12]
Jerrold
Nadler
D
NY
12
2024-10-25
False
- L000590
Rep. Lee, Susie [D-NV-3]
Susie
Lee
D
NV
3
2024-11-20
False
- T000478
Rep. Tenney, Claudia [R-NY-24]
Claudia
Tenney
R
NY
24
2024-12-05
False
- C000059
Rep. Calvert, Ken [R-CA-41]
Ken
Calvert
R
CA
41
2024-12-09
False
- D000399
Rep. Doggett, Lloyd [D-TX-37]
Lloyd
Doggett
D
TX
37
2024-12-16
False
- M000317
Rep. Malliotakis, Nicole [R-NY-11]
Nicole
Malliotakis
R
NY
11
2024-12-17
False
Health
- Administrative law and regulatory procedures
2024-04-03T20:14:48Z
- Animal protection and human-animal relationships
2024-04-03T20:14:43Z
- Congressional oversight
2024-04-03T20:17:03Z
- Department of Health and Human Services
2024-04-03T20:17:11Z
- Drug safety, medical device, and laboratory regulation
2024-04-03T20:14:33Z
- Food and Drug Administration (FDA)
2024-04-03T20:14:24Z
- Government information and archives
2024-04-03T20:14:55Z
- Internet, web applications, social media
2024-04-03T20:15:06Z
- Prescription drugs
2024-04-03T20:14:38Z
Health
2024-02-28T17:30:54Z
00
2024-02-06
Introduced in House
2024-04-01T16:15:31Z
FDA Modernization Act 3.0
This bill requires the Food and Drug Administration (FDA) to establish a process that supports nonclinical testing methods for drug development that do not involve the use of animals.
Specifically, the FDA must establish a pathway by which entities may apply to have nonclinical testing methods approved for use in a particular context. Qualifying methods must be intended to replace or reduce animal testing and to either improve the safety and efficacy of nonclinical testing or reduce the time to develop a drug. The FDA must issue its decision within 180 days of receiving an application. The FDA must also prioritize the review of applications for drugs that are developed using an approved nonclinical testing method.
The FDA must annually post a report on its website that summarizes the results of the bill's implementation, including the number of applications received, types of methods that were approved, and the estimated number of animals saved as result of these methods.

FDA Modernization Act 3.0
- Display Title
45

FDA Modernization Act 3.0
2024-06-07T21:12:16Z
- Short Title(s) as Introduced
101

FDA Modernization Act 3.0
2024-05-24T13:34:09Z
Introduced in House
IH
- Official Title as Introduced
6

To amend the Federal Food, Drug, and Cosmetic Act to establish a process for the qualification of nonclinical testing methods to reduce and replace the use of animals in nonclinical research, improve the predictivity of nonclinical testing methods, and reduce development time for a biological product or other drug, and for other purposes.
2024-03-18T22:14:46Z
Introduced in House
IH
- Introduced in House
2024-02-06T05:00:00Z
  - https://www.govinfo.gov/content/pkg/BILLS-118hr7248ih/xml/BILLS-118hr7248ih.xml
2024-02-09
Referred to the Subcommittee on Health.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.